Vertex Pharmaceuticals, Inc.
XNAS: VRTX
Vertex Pharmaceuticals, Inc. Live Stock Price Today, Share Analysis and Chart
about
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...
Read More
383.12
-3.99
(-1.03%)
3.4M
XNAS Volume
High volume today
XNAS 19 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Vertex Pharmaceuticals, Inc. is on 23 Sep 2025 for the purpose of Bank of America Global Healthcare Conference
See details
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks.
View Similar
Embed DVM
Vertex Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..